Skip to content
Search

Latest Stories

PSNC discusses with stakeholders impact of fuel crisis on community pharmacy

To discuss the ongoing fuel crisis and its impact on community pharmacy, Pharmaceutical Services Negotiating Committee (PSNC) held a meeting with stakeholders from across the supply chain, including the Department of Health and Social Care (DHSC) and NHS England and NHS Improvement (NHSE&I).

All agreed that the situation has started to improve, but acknowledged that some areas still remain affected by delays to deliveries of medicines.


The stakeholders also agreed that fuel crisis has increased the workload and stress levels for everyone across the supply chain and vowed to keep a watch on the evolving situations.

In addition to fuel crisis, the HGV driver shortages led to unpredictable deliveries of medicines into warehouses, creating logistics issues for wholesalers.

Meanwhile, the DHSC confirmed availability of sufficient stock of medicines within the supply chain.

PSNC director, legal, Gordon Hockey said: “The continued patient access to medicines throughout the fuel supply issues has been testament to the robustness of the medicines supply chain, as well as the incredible work of pharmacy teams and others across the supply chain to minimise the impact of any disruption.”

The meeting was also attended by representatives from organisations including the Royal Pharmaceutical Society (RPS), the National Pharmacy Association (NPA), the Association of Independent Multiples (AIMp), the Company Chemists Association (CCA), the General Pharmaceutical Council (GPhC) and the Consumer Healthcare Association (PAGB).

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less